HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues.

Abstract
The epidermolysis bullosa acquisita (EBA) antigen is identified as 2 chains: a 290,000-dalton protein and a less prominent 145,000-dalton protein. The 290,000-dalton chain is synthesized by human keratinocytes in culture. In this study, we show that the 290,000-dalton chain is synthesized by human skin fibroblasts and cutaneous human tumors. In contrast, HT1080 cells, a human sarcoma cell line known to produce matrix molecules (such as laminin and type IV collagen), does not synthesize the EBA antigen. Further, the EBA antigen is absent from serum and blood components, placenta, amnion, lung, and the EHS tumor, a murine sarcoma that produces large amounts of laminin, type IV collagen, nidogen, entactin, and basement membrane proteoglycan but is present in cutaneous tumors of adnexal and epithelial origin. These data suggest that while the EBA antigen is synthesized by both human skin keratinocytes and fibroblasts and is therefore not specific for a primordial germ layer, it does appear to be specific for tissue containing a stratified squamous epithelium.
AuthorsD T Woodley, R A Briggaman, W R Gammon, R J Falk, M J Reese, R S Tomsick, E J O'Keefe
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 87 Issue 2 Pg. 227-31 (Aug 1986) ISSN: 0022-202X [Print] United States
PMID3525689 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens
  • Autoantigens
  • epidermolysis bullosa acquisita antigen
Topics
  • Antigens (biosynthesis)
  • Autoantigens (biosynthesis)
  • Basement Membrane (immunology)
  • Chemical Precipitation
  • Electrophoresis, Polyacrylamide Gel
  • Fibroblasts (immunology)
  • Fluorescent Antibody Technique
  • Humans
  • Immunologic Techniques
  • Organ Specificity
  • Skin (immunology)
  • Skin Neoplasms (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: